Produção heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patens
| Ano de defesa: | 2022 |
|---|---|
| Autor(a) principal: | |
| Orientador(a): | |
| Banca de defesa: | |
| Tipo de documento: | Dissertação |
| Tipo de acesso: | Acesso aberto |
| Idioma: | por |
| Instituição de defesa: |
Universidade Católica de Brasília
|
| Programa de Pós-Graduação: |
Programa Stricto Sensu em Ciências Genômicas e Biotecnologia
|
| Departamento: |
Escola de Saúde e Medicina
|
| País: |
Brasil
|
| Palavras-chave em Português: | |
| Palavras-chave em Inglês: | |
| Área do conhecimento CNPq: | |
| Link de acesso: | https://bdtd.ucb.br:8443/jspui/handle/tede/3697 |
Resumo: | With the emergence of microbial strains resistant to antimicrobial drugs, world health is facing a crisis against pathogens that no longer respond to conventional treatments as they did. In this context, antimicrobial peptides (PAMs) stand out and research focusing on these molecules increases every day. However, these molecules are not produced in large quantities in the organisms of origin. To obtain large amounts of peptides, we can rely on several strategies, ranging from the isolation of the molecule directly from the organism that produces it, through synthesis and expression via a heterologous system. In this work, the heterologous production of the antimicrobial peptide Cp-Thionine II was carried out in the moss Physcomitrium patens through the CRISPR/Cas9 system using three transformation vectors pActCas9, pBNRf and pLand_cpt. After transformation, 4 transformed clones were obtained which, after confirmation by sequencing, were subjected to expression analysis via qRT-PCR where clone 1.4.2 was selected for large-scale production using a bioreactor. After 45 days of cultivation in a photobioreactor, a protein extraction from the plant tissue was performed and analyzed via MALDI-TOF as well as an antimicrobial activity assay using strains ATTC 25923 for Staphylococcus aureus and ATTC 25922 for Escherichia coli. The bioassay did not show activity due to the low presence of recombinant protein in the extract at commercial levels. However, considering the general difficulty of expressing peptides in plants, we can assume that the use of the CRISPR technique was essential for the peptide to be expressed in this system. |
| id |
UCB_f4bdf6688cb8badb0f2f48d03e01ae09 |
|---|---|
| oai_identifier_str |
oai:bdtd.ucb.br:tede/3697 |
| network_acronym_str |
UCB |
| network_name_str |
Biblioteca Digital de Teses e Dissertações da UCB |
| repository_id_str |
|
| spelling |
Dias, Simoni Camposhttp://lattes.cnpq.br/1564224041415405buscatextual.cnpq.brLeal, Lara Nascimento2025-07-11T20:00:40Z2022-03-23LEAL, Lara Nascimento. Produção heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patens. 2022. 69 f. Dissertação (Programa Stricto Sensu em Ciências Genômicas e Biotecnologia) - Universidade Católica de Brasília, Brasília, 2025.https://bdtd.ucb.br:8443/jspui/handle/tede/3697With the emergence of microbial strains resistant to antimicrobial drugs, world health is facing a crisis against pathogens that no longer respond to conventional treatments as they did. In this context, antimicrobial peptides (PAMs) stand out and research focusing on these molecules increases every day. However, these molecules are not produced in large quantities in the organisms of origin. To obtain large amounts of peptides, we can rely on several strategies, ranging from the isolation of the molecule directly from the organism that produces it, through synthesis and expression via a heterologous system. In this work, the heterologous production of the antimicrobial peptide Cp-Thionine II was carried out in the moss Physcomitrium patens through the CRISPR/Cas9 system using three transformation vectors pActCas9, pBNRf and pLand_cpt. After transformation, 4 transformed clones were obtained which, after confirmation by sequencing, were subjected to expression analysis via qRT-PCR where clone 1.4.2 was selected for large-scale production using a bioreactor. After 45 days of cultivation in a photobioreactor, a protein extraction from the plant tissue was performed and analyzed via MALDI-TOF as well as an antimicrobial activity assay using strains ATTC 25923 for Staphylococcus aureus and ATTC 25922 for Escherichia coli. The bioassay did not show activity due to the low presence of recombinant protein in the extract at commercial levels. However, considering the general difficulty of expressing peptides in plants, we can assume that the use of the CRISPR technique was essential for the peptide to be expressed in this system.Com o crescente surgimento de cepas microbianas resistentes aos fármacos antimicrobianos a saúde mundial enfrenta uma crise contra patógenos que já não respondem a tratamentos convencionais como respondiam. Nesse âmbito, peptídeos antimicrobianos (PAMs) se destacam e pesquisas com foco nessas moléculas aumentam a cada dia. Entretanto estas moléculas não são produzidas em grande quantidade nos organismos de origem. Para obtenção em grande quantidade de peptídeos podemos contar com várias estratégias que vão desde o isolamento da molécula direto do organismo que a produz, passando pela síntese química e a expressão via sistema heterólogo. Nesse trabalho foi realizada a produção heteróloga do peptídeo antimicrobiano Cp- Tionina II no musgo Physcomitrium patens através do sistema CRISPR/ Cas9 usando três vetores de transformação pActCas9, pBNRf e pLand_cpt. Após transformação foram obtidos 4 clones transformados que após confirmação por sequenciamento, foram submetidos a análise de expressão via qRT-PCR onde o clone 1.4.2 foi selecionado para sua produção em larga escala utilizando biorreator. Após cultivo de 45 dias em fotobiorreator, uma extração proteica do tecido vegetal foi feita e submetida a análises via MALDI-TOF bem como foi feito um ensaio de atividade antimicrobiana usando as cepas ATTC 25923 para Staphylococcus aureus e ATTC 25922 para Escherichia coli. O bioensaio não mostrou atividade devido a baixa presença da proteina recombinante no extrato Apesar de bem estabelecido como bioprodutor, na literatura não se encontra muitos relatos de P. patens expressando proteínas recombinantes menores 10kda, podendo assim não ser considerado o melhor sistema para expressão de peptídeos em níveis comerciais. Entretanto, levando em consideração a dificuldade geral de se expressar peptídeos em plantas, podemos concluir que o uso da técnica de CRISPR, foi essencial para que o peptídeo fosse expresso nesse sistema.Submitted by Ihorranna Oliveira (ihorranna.oliveira@ucb.br) on 2025-06-26T17:30:35Z No. of bitstreams: 1 LaraLealDissertacao2022.pdf: 6926058 bytes, checksum: 2777a61cd4f57c6ca03be12e70d87a4e (MD5)Approved for entry into archive by Sara Ribeiro (sara.ribeiro@ucb.br) on 2025-07-11T20:00:40Z (GMT) No. of bitstreams: 1 LaraLealDissertacao2022.pdf: 6926058 bytes, checksum: 2777a61cd4f57c6ca03be12e70d87a4e (MD5)Made available in DSpace on 2025-07-11T20:00:40Z (GMT). No. of bitstreams: 1 LaraLealDissertacao2022.pdf: 6926058 bytes, checksum: 2777a61cd4f57c6ca03be12e70d87a4e (MD5) Previous issue date: 2022-03-23application/pdfhttps://bdtd.ucb.br:8443/jspui/retrieve/12938/LaraLealDissertacao2022.pdf.jpgporUniversidade Católica de BrasíliaPrograma Stricto Sensu em Ciências Genômicas e BiotecnologiaUCBBrasilEscola de Saúde e MedicinaExpressão heterólogaPeptídeos antimicrobianosPhyscomitrium patensCRISPR/Cas9Heterologous expressionAntimicrobial peptidesPhyscomitrium patensCNPQ::CIENCIAS BIOLOGICASProdução heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patensinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da UCBinstname:Universidade Católica de Brasília (UCB)instacron:UCBLICENSElicense.txtlicense.txttext/plain; charset=utf-81905https://bdtd.ucb.br:8443/jspui/bitstream/tede/3697/1/license.txt75558dcf859532757239878b42f1c2c7MD51ORIGINALLaraLealDissertacao2022.pdfLaraLealDissertacao2022.pdfapplication/pdf6926058https://bdtd.ucb.br:8443/jspui/bitstream/tede/3697/2/LaraLealDissertacao2022.pdf2777a61cd4f57c6ca03be12e70d87a4eMD52TEXTLaraLealDissertacao2022.pdf.txtLaraLealDissertacao2022.pdf.txttext/plain115049https://bdtd.ucb.br:8443/jspui/bitstream/tede/3697/3/LaraLealDissertacao2022.pdf.txtfda0c35acb1559e9aa71a9011a9e18f8MD53THUMBNAILLaraLealDissertacao2022.pdf.jpgLaraLealDissertacao2022.pdf.jpgimage/jpeg6046https://bdtd.ucb.br:8443/jspui/bitstream/tede/3697/4/LaraLealDissertacao2022.pdf.jpg469babd935d7f8c45660f490fcb46cc6MD54tede/36972025-07-12 13:01:28.027oai:bdtd.ucb.br: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 Digital de Teses e Dissertaçõeshttps://bdtd.ucb.br:8443/jspui/PRIhttps://bdtd.ucb.br:8443/oai/requestsdi@ucb.bropendoar:47812025-07-12T13:01:28Biblioteca Digital de Teses e Dissertações da UCB - Universidade Católica de Brasília (UCB)false |
| dc.title.por.fl_str_mv |
Produção heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patens |
| title |
Produção heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patens |
| spellingShingle |
Produção heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patens Leal, Lara Nascimento Expressão heteróloga Peptídeos antimicrobianos Physcomitrium patens CRISPR/Cas9 Heterologous expression Antimicrobial peptides Physcomitrium patens CNPQ::CIENCIAS BIOLOGICAS |
| title_short |
Produção heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patens |
| title_full |
Produção heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patens |
| title_fullStr |
Produção heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patens |
| title_full_unstemmed |
Produção heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patens |
| title_sort |
Produção heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patens |
| author |
Leal, Lara Nascimento |
| author_facet |
Leal, Lara Nascimento |
| author_role |
author |
| dc.contributor.advisor1.fl_str_mv |
Dias, Simoni Campos |
| dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/1564224041415405 |
| dc.contributor.authorLattes.fl_str_mv |
buscatextual.cnpq.br |
| dc.contributor.author.fl_str_mv |
Leal, Lara Nascimento |
| contributor_str_mv |
Dias, Simoni Campos |
| dc.subject.por.fl_str_mv |
Expressão heteróloga Peptídeos antimicrobianos |
| topic |
Expressão heteróloga Peptídeos antimicrobianos Physcomitrium patens CRISPR/Cas9 Heterologous expression Antimicrobial peptides Physcomitrium patens CNPQ::CIENCIAS BIOLOGICAS |
| dc.subject.eng.fl_str_mv |
Physcomitrium patens CRISPR/Cas9 Heterologous expression Antimicrobial peptides Physcomitrium patens |
| dc.subject.cnpq.fl_str_mv |
CNPQ::CIENCIAS BIOLOGICAS |
| description |
With the emergence of microbial strains resistant to antimicrobial drugs, world health is facing a crisis against pathogens that no longer respond to conventional treatments as they did. In this context, antimicrobial peptides (PAMs) stand out and research focusing on these molecules increases every day. However, these molecules are not produced in large quantities in the organisms of origin. To obtain large amounts of peptides, we can rely on several strategies, ranging from the isolation of the molecule directly from the organism that produces it, through synthesis and expression via a heterologous system. In this work, the heterologous production of the antimicrobial peptide Cp-Thionine II was carried out in the moss Physcomitrium patens through the CRISPR/Cas9 system using three transformation vectors pActCas9, pBNRf and pLand_cpt. After transformation, 4 transformed clones were obtained which, after confirmation by sequencing, were subjected to expression analysis via qRT-PCR where clone 1.4.2 was selected for large-scale production using a bioreactor. After 45 days of cultivation in a photobioreactor, a protein extraction from the plant tissue was performed and analyzed via MALDI-TOF as well as an antimicrobial activity assay using strains ATTC 25923 for Staphylococcus aureus and ATTC 25922 for Escherichia coli. The bioassay did not show activity due to the low presence of recombinant protein in the extract at commercial levels. However, considering the general difficulty of expressing peptides in plants, we can assume that the use of the CRISPR technique was essential for the peptide to be expressed in this system. |
| publishDate |
2022 |
| dc.date.issued.fl_str_mv |
2022-03-23 |
| dc.date.accessioned.fl_str_mv |
2025-07-11T20:00:40Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
| format |
masterThesis |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
LEAL, Lara Nascimento. Produção heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patens. 2022. 69 f. Dissertação (Programa Stricto Sensu em Ciências Genômicas e Biotecnologia) - Universidade Católica de Brasília, Brasília, 2025. |
| dc.identifier.uri.fl_str_mv |
https://bdtd.ucb.br:8443/jspui/handle/tede/3697 |
| identifier_str_mv |
LEAL, Lara Nascimento. Produção heteróloga do peptídeo antimicrobiano Cp- Tionina II em Physcomitrium patens. 2022. 69 f. Dissertação (Programa Stricto Sensu em Ciências Genômicas e Biotecnologia) - Universidade Católica de Brasília, Brasília, 2025. |
| url |
https://bdtd.ucb.br:8443/jspui/handle/tede/3697 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Universidade Católica de Brasília |
| dc.publisher.program.fl_str_mv |
Programa Stricto Sensu em Ciências Genômicas e Biotecnologia |
| dc.publisher.initials.fl_str_mv |
UCB |
| dc.publisher.country.fl_str_mv |
Brasil |
| dc.publisher.department.fl_str_mv |
Escola de Saúde e Medicina |
| publisher.none.fl_str_mv |
Universidade Católica de Brasília |
| dc.source.none.fl_str_mv |
reponame:Biblioteca Digital de Teses e Dissertações da UCB instname:Universidade Católica de Brasília (UCB) instacron:UCB |
| instname_str |
Universidade Católica de Brasília (UCB) |
| instacron_str |
UCB |
| institution |
UCB |
| reponame_str |
Biblioteca Digital de Teses e Dissertações da UCB |
| collection |
Biblioteca Digital de Teses e Dissertações da UCB |
| bitstream.url.fl_str_mv |
https://bdtd.ucb.br:8443/jspui/bitstream/tede/3697/1/license.txt https://bdtd.ucb.br:8443/jspui/bitstream/tede/3697/2/LaraLealDissertacao2022.pdf https://bdtd.ucb.br:8443/jspui/bitstream/tede/3697/3/LaraLealDissertacao2022.pdf.txt https://bdtd.ucb.br:8443/jspui/bitstream/tede/3697/4/LaraLealDissertacao2022.pdf.jpg |
| bitstream.checksum.fl_str_mv |
75558dcf859532757239878b42f1c2c7 2777a61cd4f57c6ca03be12e70d87a4e fda0c35acb1559e9aa71a9011a9e18f8 469babd935d7f8c45660f490fcb46cc6 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Biblioteca Digital de Teses e Dissertações da UCB - Universidade Católica de Brasília (UCB) |
| repository.mail.fl_str_mv |
sdi@ucb.br |
| _version_ |
1862729503155945472 |